Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats

The Rat Brain in Stereotaxic Coordinates

1982 • 53,055 citations

The rat brain in stereotaxic coordinates

1983 • 28,962 citations

Bupropion: a review of its mechanism of antidepressant activity.

1995 • 693 citations

A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine

1974 • 461 citations

The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.

1992 • 456 citations

Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons

1987 • 374 citations

Morphological and Functional Aspects of Central Monoamine Neurons

1970 • 349 citations

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

1994 • 317 citations

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

1998 • 278 citations

Dopamine and depression: A review of recent evidence. I. Empirical studies

1983 • 267 citations

Inhibition by fluoxetine of cytochrome P450 2D6 activity

1993 • 259 citations

Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis

1993 • 256 citations

Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test

1998 • 246 citations

Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum

1992 • 218 citations

The mesolimbic dopamine system as a target for rapid antidepressant action

1997 • 209 citations

Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.

1980 • 203 citations

Effect of an uptake inhibitor on serotonin metabolism in rat brain: Studies with 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine (Lilly 110140)

1974 • 202 citations

Evidence that the Acute Behavioral and Electrophysiological Effects of Bupropion (Wellbutrin®) Are Mediated by a Noradrenergic Mechanism

1994 • 188 citations

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

1999 • 171 citations

Combining Serotonin Reuptake Inhibitors and Bupropion in Partial Responders to Antidepressant Monotherapy

1997 • 161 citations

Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization.

1996 • 134 citations

Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis

1989 • 134 citations

Pharmacokinetic Drug Interactions of New Antidepressants: A Review of the Effects on the Metabolism of Other Drugs

1997 • 132 citations

Studies of bupropion's mechanism of antidepressant activity.

1983 • 125 citations

Metabolism and kinetics of bupropion.

1983 • 119 citations

Double-blind comparison of bupropion and fluoxetine in depressed outpatients.

1991 • 109 citations

Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum.

1992 • 109 citations

The role of noradrenaline in depression: a review.

1997 • 101 citations

Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders.

1987 • 96 citations

Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons

1989 • 91 citations

Carbamazepine but not Valproate Induces Bupropion Metabolism

1995 • 89 citations

Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses

1991 • 88 citations

Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: Evidence for facilitatory 5-HT receptors within the CNS

1986 • 85 citations

Bupropion in Depression

1988 • 81 citations

Pharmacological significance of the species differences in bupropion metabolism

1987 • 78 citations

Antidepressant Profile of Bupropion and three Metabolites in Mice

1990 • 72 citations

The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats

1975 • 69 citations

Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex

1999 • 64 citations

Functional Interaction between Serotonin and Other Neuronal Systems: Focus on In Vivo Microdialysis Studies

1996 • 60 citations

Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus <scp>l</scp>-5-hydroxytryptophan

1993 • 60 citations

A double‐blind study of L‐sulpiride versus amitriptyline in lithium‐maintained bipolar depressives

1993 • 59 citations

Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats

1997 • 57 citations

Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.

1995 • 55 citations

Development of Antidepressant Drugs

1995 • 51 citations

Selective Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs)

1995 • 44 citations

Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors.

1995 • 39 citations

Pharmacology in vivo of the phenylindan derivative, lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain

1985 • 39 citations

Dopamine Autoreceptor Agonists in the Treatment of Schizophrenia and Major Depression*

1992 • 38 citations

Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system

1997 • 35 citations

Daily bupropion injections for 3 weeks attenuate the ne-stimulation of adenylate cyclase and the number of β-adrenergic recognition sites in rat frontal cortex

1983 • 34 citations

Review of bupropion

1983 • 26 citations

Bupropion and sertraline combination treatment in refractory depression

1995 • 19 citations

On the In-vivo Modulation of Neostriatal Dopamine Release by Fluoxetine and 5−Hydroxy-L-tryptophan in Conscious Rats

1996 • 14 citations

Actions of A-75200, a novel catecholamine uptake inhibitor, on norepinephrine uptake and release from bovine adrenal chromaffin cells.

1993 • 11 citations

Effect of bupropion on dopamine and 5-hydroxytryptamine-mediated behaviour in mice

1984 • 11 citations

GBR 13098, a selective dopamine uptake inhibitor; behavioural, biochemical and electrophysiological studies

1986 • 7 citations

Repeated imipramine enhances sensitivity of the brain dopaminergic system related to exploratory behavior

1987 • 7 citations

Noradrenaline in depression: half a century of progress.

1997 • 6 citations